Norihiro Watanabe

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Radiation Therapy

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Nature biotechnology

Cancer discovery

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihiro Watanabe, Valentina Hoyos, Premal D Lulla, Ann M Leen
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood (2024)
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihiro Watanabe, Valentina Hoyos, Premal D Lulla, Ann M Leen
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood (2024)
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihiro Watanabe, Valentina Hoyos, Premal D Lulla, Ann M Leen
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood (2024)
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihiro Watanabe, Valentina Hoyos, Premal D Lulla, Ann M Leen
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood 143 (17) (2024)
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihiro Watanabe, Valentina Hoyos, Premal D Lulla, Ann M Leen
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood 143 (17) (2024)
Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihiro Watanabe, Valentina Hoyos, Premal D Lulla, Ann M Leen
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood 143 (17) (2024)
Feiyan Mo, Norihiro Watanabe, Kayleigh Ingersoll Omdahl, Phillip M Burkhardt, Xiaoyun Ding, Eiko Hayase, Angela Panoskaltsis-Mortari, Robert R Jenq, Helen E Heslop, Leslie S Kean, Malcolm K Brenner, Victor Tkachev, Maksim Mamonkin
Engineering T cells to suppress acute GvHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood (2022)
Feiyan Mo, Norihiro Watanabe, Mary K McKenna, M John Hicks, Madhuwanti Srinivasan, Diogo Gomes-Silva, Erden Atilla, Tyler Smith, Pinar Ataca Atilla, Royce Ma, David Quach, Helen E Heslop, Malcolm K Brenner, Maksim Mamonkin
Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nature biotechnology 39 (1) (2020)
Alejandro Torres Chavez, Mary Kathryn McKenna, Emanuele Canestrari, Christina T Dann, Carlos A Ramos, Premal Lulla, Ann M Leen, Juan F Vera, Norihiro Watanabe
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity. Journal for immunotherapy of cancer 7 (1) (2019)
Sujita Sukumaran, Norihiro Watanabe, Pradip Bajgain, Kanchana Raja, Somala Mohammed, William E Fisher, Malcolm K Brenner, Ann M Leen, Juan F Vera
Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer discovery 8 (8) (2018)